Evaluation of AaDOP2 receptor antagonists reveals antidepressants and antipsychotics as novel lead molecules for control of the yellow fever mosquito, Aedes aegypti.

@article{Conley2015EvaluationOA,
  title={Evaluation of AaDOP2 receptor antagonists reveals antidepressants and antipsychotics as novel lead molecules for control of the yellow fever mosquito, Aedes aegypti.},
  author={Jason M. Conley and Jason M. Meyer and Andrew Bradley Nuss and Trevor B. Doyle and Sergey Savinov and Catherine A. Hill and Val J. Watts},
  journal={The Journal of pharmacology and experimental therapeutics},
  year={2015},
  volume={352 1},
  pages={53-60}
}
The yellow fever mosquito, Aedes aegypti, vectors disease-causing agents that adversely affect human health, most notably the viruses causing dengue and yellow fever. The efficacy of current mosquito control programs is challenged by the emergence of insecticide-resistant mosquito populations, suggesting an urgent need for the development of chemical… CONTINUE READING